| 3.2 -0.5 (-14.33%) | 10-07 15:07 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.15  |
1-year : | 4.73 |
| Resists | First : | 3.55 |
Second : | 4.05 |
| Pivot price | 3.77 |
|||
| Supports | First : | 2.75 |
Second : | 2.28 |
| MAs | MA(5) : | 3.72 |
MA(20) : | 3.7 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 51.7 |
D(3) : | 61.5 |
| RSI | RSI(14): 39.7 |
|||
| 52-week | High : | 4.05 | Low : | 1.12 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AONC ] has closed below the lower bollinger band by 16.5%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 3.57 - 3.6 | 3.6 - 3.61 |
| Low: | 2.71 - 2.73 | 2.73 - 2.75 |
| Close: | 3.17 - 3.2 | 3.2 - 3.23 |
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Wed, 31 Jul 2024
American Oncology Network Announces Second Quarter 2024 Earnings Release Date and Conference Call - Yahoo Finance
Mon, 10 Jun 2024
American Oncology Network Announces the Commencement of OTCQX Trading - Yahoo Finance
Tue, 21 May 2024
American Oncology Network Announces Voluntary Delisting From Nasdaq - GlobeNewswire
Wed, 15 May 2024
American Oncology Network, Inc. Announces First Quarter 2024 Financial Results - Yahoo Finance
Fri, 03 May 2024
American Oncology Network Announces CFO Transition - Yahoo Finance
Thu, 28 Mar 2024
American Oncology Network, Inc. (“AON”) Announces Fourth Quarter and Full Year 2023 Financial Results - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 13 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 35.4 (%) |
| Held by Institutions | 0.1 (%) |
| Shares Short | 11 (K) |
| Shares Short P.Month | 23 (K) |
| EPS | -2.95 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2.97 |
| Profit Margin | 0.1 % |
| Operating Margin | -1.7 % |
| Return on Assets (ttm) | -6.2 % |
| Return on Equity (ttm) | -65.1 % |
| Qtrly Rev. Growth | 37.7 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 112.04 |
| EBITDA (p.s.) | -2.42 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | 33 (M) |
| PE Ratio | -1.09 |
| PEG Ratio | 0 |
| Price to Book value | -1.09 |
| Price to Sales | 0.02 |
| Price to Cash Flow | -8.99 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|